Abstract:Aim To explore the diagnostic value of multimodal imaging techniques, including automatic breast volume scanner (ABVS), mammography (MG), and magnetic resonance (MRI) in breast sclerosing adenosis (SA) associated with malignant lesions. Methods From January 2018 to October 2020, 76 patients (88 lesions) with pathologically confirmed as SA associated with malignant or benign lesions were retrospective analyzed. All patients completed ABVS examination, 58 patients (67 lesions) with MG and 50 patients (62 lesions) with MRI were also completed before biopsy or surgical excision, of which, six patients (eight lesions) diagnosed as Breast Imaging Reporting and Data System (BI-RADS) category 3 by all imaging examinations underwent surgical excision without biopsy, other 70 patients (80 lesions) with BI-RADS category 4 or above by any imaging examination completed biopsy, including 65 patients (75 lesions) were further surgical excised and the other five patients (five lesions) were just followed up. All lesions were retrospectively described and classified, and were divided into benign group and malignant group according to their pathological results. Image features of different examination methods between the two groups were compared and analyzed. A ROC curve was established using the sensitivity of BI-RADS categories to predict malignant lesions in different imaging techniques as the ordinate and 1-specificity as the abscissa. Results 88 lesions including 26 purely SA and 45 SA associated with benign lesions were classified as benign group, and the remaining 17 SA associated with malignant lesions were classified as malignant group. On ABVS, 40 mass lesions, their heterogeneous echo, not circumscribed margin and coronal convergence signs were statistically significant for malignant lesions (p < .05), but the remain 48 nonmass lesions lack specific sonographic features. On MG, 12 showed negative results, 55 showed with microcalcification, mass, structural distortion, and asymmetric density shadow, of which 11 lesions had the above two signs at the same time, but only microcalcification had statistical difference between the two groups. 35 mass enhanced lesions and 27 nonmass enhanced lesions on MRI, but there were no significant difference between their pathological results. Time signal intensity curves showed no differences, but ADC value <1.10 x 10(-3) mm(2)/s is more significant in malignant lesions (p < .05). The area under the ROC curve (AUC) of BI-RADS classification of ABVS, MG, and MRI in the diagnosis of malignant lesions were 0.611, 0.474, and 0.751, respectively, and the AUC of the combined diagnosis of the three was 0.761. Conclusion Mass lesions with heterogeneous echo, not circumscribed margin and coronal convergence sign on ABVS, microcalcification on MG and the ADC value <1.10 x 10(-3) mm(2)/s on MRI are significant signs for SA associated with malignant lesions. The combined diagnosis of the three methods was the highest, and the following were MRI, ABVS, and MG. Therefore, be cognizant of significant characteristics in SA associated with malignancy showed in different imaging examinations can improve the preoperative evaluation of SA and better provide basis for subsequent clinical decision-making.

US and CEUS Features and Misdiagnosis Analysis of Breast Sclerosing Adenosis

Diagnostic Evaluations of Ultrasound and Magnetic Resonance Imaging in Mammary Duct Ectasia and Breast Cancer

Value of Contrast-Enhanced Ultrasound and Enhancement Patterns in the Diagnosis of Adrenal Tumors

Application of Ultrasound and Contrast-Enhanced Ultrasound to Distinguish Salivary Focal Inflammatory Masses from Malignant Masses: A Retrospective Observational Study

Sclerosing Adenosis: Ultrasonographic and Mammographic Findings and Correlation with Histopathology.

Contrast-enhanced Ultrasound for the Differential Diagnosis Between Benign and Metastatic Superficial Lymph Nodes: a Meta-Analysis

A Diagnostic Model for Breast Lesions with Enlarged Enhancement Extent on Contrast-Enhanced Ultrasound Improves Malignancy Prediction

Value of Scoring by Contrast-Enhanced Ultrasound Combined with Ultrasonic Elastography in Differential Diagnosis of BI-RADS 4 Lesions

Meta‐analysis of contrast‐enhanced ultrasound in differential diagnosis of breast adenosis and breast cancer

Multimodal ultrasound imaging for diagnostic differentiation of sclerosing adenosis from invasive ductal carcinoma

Misdiagnosis Analysis of Renal Benign and Malignant Tumors with Contrast-Enhanced Ultrasound

Value of Multimodal Imaging in the Diagnosis of Breast Sclerosing Adenosis Associated with Malignant Lesions.

Diagnostic performance of contrast-enhanced ultrasound and enhanced magnetic resonance for breast nodules

Diagnostic Accuracy of Contrast-Enhanced Ultrasound Synchronized with Shear Wave Elastography in the Differential Diagnosis of Benign and Malignant Breast Lesions: a Diagnostic Test

Percutaneous contrast-enhanced ultrasonography in diagnosis of metastatic sentinel lymph nodes from breast carcinoma

The Differential Diagnostic Value of Contrast-enhanced Ultrasonography in BI-RADSUS 4B Breast Lesions

Breast Non-Mass-like Lesions on Contrast-Enhanced Ultrasonography: Feature Analysis, Breast Image Reporting and Data System Classification Assessment

Computer‐Aided Diagnosis of Solid Breast Lesions With Ultrasound: Factors Associated With False‐negative and False‐positive Results

Role of Contrast-Enhanced Ultrasound in Pulmonary Lesions: 5-Year Experience at a Single Center

Clinical Value of Contrast-Enhanced Ultrasound in Improving Diagnostic Accuracy Rate of Transthoracic Biopsy of Anteriormedial Mediastinal Lesions

The Value of Percutaneous Contrast-Enhanced Ultrasound in Sentinel Lymph Node Identification, Metastatic Status and Burden Diagnosis in Early Breast Cancer